Stimulated PBMC-produced IFN- and TNF- are associated with altered relapse risk in multiple sclerosis: results from a prospective cohort study-Reference-Cited by-同舟云学术

Stimulated PBMC-produced IFN- and TNF- are associated with altered relapse risk in multiple sclerosis: results from a prospective cohort study

Published:2014-05-01 Issue:2 Volume:86 Page:200-207
ISSN:0022-3050
Container-title:Journal of Neurology, Neurosurgery & Psychiatry
language:en
Short-container-title:Journal of Neurology, Neurosurgery & Psychiatry

Author:

Simpson S.,Stewart N.,van der Mei I.,Otahal P.,Charlesworth J.,Ponsonby A.-L.,Blizzard L.,Dwyer T.,Pittas F.,Gies P.,Taylor B.

Publisher

BMJ

Subject

Psychiatry and Mental health,Neurology (clinical),Surgery

Reference29 articles.

1. Review: cytokines and the pathogenesis of multiple sclerosis;Navikas;J Neurosci Res,1996

2. Evidence for cytokine dysregulation in multiple sclerosis: peripheral blood mononuclear cell production of pro-inflammatory and anti-inflammatory cytokines during relapse and remission;Hollifield;Autoimmunity,2003

3. Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations?;Beck;Acta Neurol Scand,1988

4. Tumor necrosis factor alpha production as a possible predictor of relapse in patients with multiple sclerosis;Chofflon;Eur Cytokine Netw,1992

5. Tumor necrosis factor production capacity as a potentially useful parameter to monitor disease activity in multiple sclerosis;Chofflon;Eur Cytokine Netw,1997

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ursolic acid derivative UAOS-Na treats experimental autoimmune encephalomyelitis by immunoregulation and protecting myelin;Frontiers in Neurology;2023-11-30

2. Ursolic Acid Reduces Inflammation in Experimental Autoimmune Encephalomyelitis by Suppressing the Tnf-Α/Nf-Κb Signaling Pathway;2023

3. Lack of association between TNFA and TNFB polymorphisms and the risk of multiple sclerosis: a meta-analysis from 37 studies;Expert Review of Clinical Immunology;2022-08-30

4. Predictors of progression from a first demyelinating event to clinically definite multiple sclerosis;Brain Communications;2022-07-04

5. IFN-γ and TNF-α Gene Polymorphisms in Multiple Sclerosis Patients in Northwest Iran;Endocrine, Metabolic & Immune Disorders - Drug Targets;2021-03